Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial - Annals of
Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation | Scientific Reports
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
ROC analysis of the pretreatment AAPR by setting overall survival as... | Download Scientific Diagram
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 24 Issue 9 (2017)
Figure: QUAZAR AML-001 primary endpoint: overall survival from... | Download Scientific Diagram
Kaplan-Meier estimates of (a) the primary endpoint of progression free... | Download Scientific Diagram
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis - The Lancet Oncology
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer† - Annals of Oncology
Evolving Oncology Endpoints - IQVIA
Clinical Trial Design - Endpoints - Quantics Biostatistics
Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial -
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy? - Annals of Oncology
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia | Leukemia
Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma - Digestive and Liver Disease
CDISC SDTM and ADaM for survival data - ppt download
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival - Journal of Hepatology
Efficacy endpoints in Oncology
Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists | BMC Cancer | Full Text
Progression‑free survival of first‑line treatment with molecular‑targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
JAMA Oncology on Twitter: "Radiographic progression-free survival in PREVAIL trial of #enzalutamide vs placebo for met castration-resistant #ProstateCancer is reliable & clinically meaningful endpoint highly assoc'd w overall survival https://t.co ...
